A worker checks cannabis plants in a Tilray medical cannabis producer greenhouse. Photograph by Patricia De Melo Moreira/AFP/Getty Images
Tilray stock soared before Canada legalized the recreational use of marijuana in October, but the gains have mostly faded away. Friday, though, the stock closed up 7.4% at $49.85 as the company’s next earnings report approached.
Tilray (ticker: TLRY) is down 29% in 2019, while the S&P 500 is up 15%. The grower’s stock closed as high as $214.06 in September.
Recent Comments